Indian scientists have created an indigenous, IP-free gene-editing tool using TnpB proteins, offering a cheaper alternative to CRISPR-Cas9. It enables precise edits without foreign genes, supporting resilient, nutrient-rich crops. Despite eased rules for SDN-1/2 crops, regulatory gaps, ethics, and public distrust after the GM Mustard debate remain major hurdles.
Click to View MoreThe Biotech sector in India is experiencing rapid growth, fueled by innovation, government initiatives, and international demand. However, challenges such as funding shortages, fragmented infrastructure, and outdated regulations impede its full potential. To become a global leader, India must streamline biotech clusters, attract late-stage investment, update regulations, and develop skilled talent for sustainable, innovation-driven growth.
Click to View MoreAMT-130 gene therapy reduces Huntington’s disease progression by 75% over three years via a single injection silencing the mutant gene. This breakthrough redefines treatment, inspiring hope while raising cost-accessibility challenges under India’s Rare Disease Policy.
Click to View MoreCalifornia Institute of Technology researchers have developed Single Shot Microscopy (SSM), an advanced imaging technique that captures high-resolution images of molecules in nanoseconds. SSM offers benefits like speed, live-cell imaging, and clarity, and has the potential to revolutionize fields like biomedical research, materials science, and clinical diagnostics.
Click to View More
© 2025 iasgyan. All right reserved